Harpagophytum BIO : complément alimentaire en gélule à base d'extrait sec concentré d'harpagophytum
Food supplement declared in France, declaration No 2019-3-1124
Harpagophytum BIO : complément alimentaire en gélule à base d'extrait sec concentré d'harpagophytum (L'Herbôthicaire) is a food supplement declared in France. Status: withdrawn from the market on 28 July 2025. Main ingredients: Harpagophytum procumbens 200 mg per day. None of the rules we check flags an issue with its declared composition.
- Brand
- L'Herbôthicaire
- Food business operator placing the product on the market
- ACBNature
- Status
- Withdrawn from the market on 28 July 2025
- Form
- Capsule
- Daily dose
- 200 mg
- Directions for use
- 1 gélule par jour avec un grand verre d'eau
- Intended populations
- Adolescents aged 11 to 17, People over 60, Men, Women
- Not recommended (according to the manufacturer)
- Breastfeeding women, Kidney stones, Pregnant women, Ulcer (stomach or duodenum)
- Objectives stated by the manufacturer (these are not authorised claims)
- Joints
Declaration 163391, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Harpagophytum procumbens | Racine | Autre extrait sec | 200 mg |
Additives
E414
Other ingredients
Gélule végétale, maltodextrine
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Déconseillé aux femmes enceintes et allaitantes et en cas d'ulcères ou de calculs. Ce complément alimentaire n'est pas un médicament. En cas de doute, toujours se référer à l'avis d'un professionnel de santé. Ne pas dépasser les doses conseillées. A consommer dans le cadre d'un mode de vie sain. Les compléments alimentaires ne doivent pas être utilisés comme substitut d'un régime alimentaire varié et équilibré. Tenir hors de la portée des enfants. Conserver dans son emballage à l'abri de la lumière, de la chaleur et de l'humidité.
Regulatory points
- Information
Withdrawn from the market on 28 July 2025, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Harpagophytum procumbens
Read the warning, when it applies and the studies cited
DEVIL'S CLAW - HARPAGOPHYTUM
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : L'Herbôthicaire
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Harpagophytum BIO : complément alimentaire en gélule à base d'extrait sec concentré d'harpagophytum (L'Herbôthicaire): composition and regulation”, https://compoatlas.com/en/supplements/products/163391-harpagophytum-bio-complement-alimentaire-en-gelule-a-base-d, updated 15 November 2026.